Predict your next investment

Angel Investor (Individual)

See what CB Insights has to offer

Investments

1

About Michael Schenden

Michael Schenden Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Michael Schenden News

Forever Labs Secures $2M in Funding

May 10, 2018

Forever Labs , a Ann Arbor, MI–based a longevity company company that banks young adult stem cells, secured $2m in funding. Backers included Northwestern Mutual, Silicon Badia Ventures, Babel Ventures, Aaron Hirschhorn, Michael Dobryansky, Timothy Davis, Michael Schenden, among others. The company intends to use the funds to continue developing its solutions and accelerate brand development. Founded in 2015 by Steven Clausnitzer, CEO, and Mark Katakowski, PhD, President, Forever Labs is a longevity company preserving healthy stem cells for future therapies that combat age-related diseases, as well as aging itself. The proprietary procedure involves a certified physician collecting one’s mesenchymal stem cells (MSCs), which have the ability to stimulate tissues to grow and repair themselves when people need it most. After a simple, 15-minute outpatient procedure, the stem cells are cryogenically frozen and stored agnostically in an FDA-compliant clinical-grade biorepository until needed. FinSMEs 10/05/2018

Michael Schenden Investments

1 Investments

Michael Schenden has made 1 investments. Their latest investment was in Forever Labs as part of their Seed VC on May 5, 2018.

CBI Logo

Michael Schenden Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/10/2018

Seed VC

Forever Labs

$2M

Yes

2

Date

5/10/2018

Round

Seed VC

Company

Forever Labs

Amount

$2M

New?

Yes

Co-Investors

Sources

2

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.